Name: Xu Ye
Title:Associate Professor Vice-Chair of Colorectal Surgery  General Secretary, Colorectal Cancer Group of Shanghai Center for Disease Control and Prevention

Education & Professional Experience   6/2003 – Current Shanghai Cancer Hospital, Fudan University.
10/2000-10/2002 Brigham and Women’s Hospital, Harvard Medical School. Postdoctor, Urology Lab, Dept of Surgery 
1997–2003 Shanghai Cancer Hospital, Fudan University. Master-Doctorate program, Dept of Surgery
12/1993–8/1997 Shanghai 1st people’s Hospital,Resident, Dept of Pediatric Surgery 
1992-1986 Shanghai Second Medical University Undergraduate Student 
7/1992–12/1993 Shanghai Xinhua Hospital, Shanghai 2nd Medical University Resident, Dept of Anesthesia

Specialty   Colorectal Cancer, Gastrointestinal Surgery,
Research   Early Detection, Liver Metastasis, Hereditary Colorectal Cancer
Publication   1.Jiang Z, Li C, Xu Y, et al. A meta-analysis on XRCC1 and XRCC3 polymorphisms and colorectal cancer risk. International J Colorectal Dis. 2010,25(2):16

2.Cai GX, Xu Y, Lian P, Peng JJ, Wang MH, Guan ZQ, Cai SJ, Tang DF. The interaction between synchronous bilateral prophylactic oophorectomy and adjuvant chemotherapy in female patients with locally advanced colorectal cancer. Colorectal Dis. 2009 Dec 21.

3.Jiang Z, Xu Y, Cai S. CXCL10 expression and prognostic significance in stage II and III colorectal cancer. Mol Biol Rep. 2009 Oct 10.

4.Cai G, Xu Y, Zhu X, Peng J, Li Z, Xiao C, Du X, Zhu J, Lian P, Sheng W, Guan Z, Cai S. A simple scoring system based on clinical features to predict locally advanced rectal cancers. J Gastrointest Surg. 2009 Jul;13(7):1299-305.

5.Cai G, Zhu X, Xu Y, Du X, Zhang Z, Zhang Y, Chen T, Zhou X, Guan Z, Cai S. Case report of extrarenal rhabdoid tumor of pelvic retroperitoneum molecular profile of angiogenesis and its implication in new treatment strategy. Cancer Biol Ther. 2009 Mar;8(5):417-21.

6.Shen W, Xiong H, Xu Y, Cai S, Lu H, Yang P. ZnO-poly(methyl methacrylate) nanobeads for enriching and desalting low-abundant proteins followed by directly MALDI-TOF MS analysis. Anal Chem. 2008 Sep 1;80(17):6758-63.

7.JJ Peng, Ye Xu, ZQ Guan, J Zhu, MH Wang, GX Cai, WQ Sheng, SJ Cai. Prognostic Significance of the Metastatic Lymph Node Ratio in Node-Positive Rectal Cancer. Annals of Surgical Oncology. 2008;Sep 3.

8.WW Shen, HM Xiong, Ye Xu, SJ Cai, HJ Lu, PY Yang. ZnO-Poly(methyl methacrylate) Nanobeads for Enriching and Desalting Low-Abundant Proteins Followed by Directly MALDI-TOF MS Analysis. Analytical Chemistry . 2008;80(17):6758-6763.

9.GX Cai, Ye Xu, HF Lu, YQ Shi, P Lian, JJ Peng, X Du, XY Zhou, ZQ Guan, DR Shi, SJ Cai. Clinicopathologic and molecular features of sporadic microsatellite and chromosomal stable colorectal cancers. International Journal of Colorectal Disease, 2008;11

10.JJ Peng, JJ Lu, J Zhu, Ye Xu, HF Lu, P Lian, CX Cai, SJ Cai. Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer. Cancer J. 2008;14:54-61

11.JJ Peng, SJ Cai, HF Lu, GX Cai, P Lian, ZQ Guan, MH Wang, Ye Xu Using molecular markers predicting the prognosis of rectal cancer undergone total mesorectal excision. World Journal of Gastroenterology 2007;13(21):3009-3015.(Corresponding Author)

12.Ye Xu, SJ Cai, Diagnosis and Treatment of anorectal melanoma. China Oncology 2007;17(6):. (First Author)

13.Ye Xu, SJ Cai, MH Sun, SJ Mo, DR Shi. Evaluation of Microsatellite Instability for Detection of Chinese Hereditary Nonpolyposis Colorectal Cancer Patients. China Oncology 2006;16(2):128-131(First Author)

14.Ye Xu, W Deng, SJ Cai, SJ Mo, MH Sun, GX Cai, P Lian, ZQ Guan, DR Shi. Analysis of Life Time Risk of Different Cancers in Patients with Hereditary Nonpolyposis Colorectal Cancer. Cancer Research and Clinic 2005;17(5):298-301 (First Author)
Awards   •First Prize Winner of AUA/Circon-ACMI Prize Essay Contest 2002
•Third Prize Winner of Shanghai Science and Technology Progression Award 2003
Out-patient Schedule  

Tuesday Morning